Articles from Biotech Financial Reports (January 1, 2004)

1-3 out of 3 article(s)

Title	Type	Words
AGILENT RETURNS TO PROFITABILITY IN 4TH QTR 2003.	Company Profile	1052
BIOXEL PHARMA REPORTS NET LOSS OF $3.5 MILLION FOR 9 MONTHS.	Company Profile	1082
MEDCATH REPORTS 4TH QTR NET REVENUE INCREASED 30.7%.	Company Profile	1124

Publications by Name	Publications by Date	Authors	Literature
A-D E-O P-T U-Z	80 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08	A B C D E F G H I J K L M N O P Q R S T U V W X Y Z	A B C D E F G H I J K L M N O P Q R S T U V W X Y Z